CDx development Qiagen, Neuron23 Partner for NGS-Based Parkinson's Disease Companion Diagnostic The collaboration will expand Qiagen's NGS testing portfolio for precision medicine beyond oncology into neurology applications. BioMérieux, Boehringer Ingelheim, Evotec Launch €40M AMR-Targeted Joint Venture Called Aurobac Therapeutics, the joint venture will develop new antimicrobial drugs and companion diagnostics. Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection The CDx pan-cancer indication will allow the identification of patients with NTRK gene fusions who may benefit from therapy with Bayer's Vitrakvi (larotrectinib). Avalon GloboCare, Lu Daopei Hematology Institute Partner to Develop Cell Therapy CDx The deal, which is subject to negotiation, will help Avalon create diagnostics for personalizing its current and future cell immunotherapy programs. Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines The collaboration aims to utilize the sequencing giant's data analytics platforms and lab services to speed up the development of personalized therapies. Dec 9, 2021 FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug May 21, 2021 FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC Dec 23, 2020 Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China Sep 25, 2020 Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib Jun 23, 2020 Thermo Fisher Scientific, Daiichi Sankyo Partner to Develop Non-Small Cell Lung Cancer CDx Mar 30, 2020 Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic Mar 25, 2020 AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic Mar 24, 2020 SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological Signatures for Cancers Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Dec 4, 2019 FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray Dec 3, 2019 Illumina, ArcherDx Expand Partnership on NGS IVD Tests Nov 25, 2019 Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies Nov 6, 2019 Merck, Promega Collaborate to Develop MSI CDx for Keytruda Oct 8, 2019 Novogene, Chipscreen Ink CDx Development Deal Oct 7, 2019 Qiagen Partners With Illumina on NGS IVD Kits; CEO Departing; Preliminary Q3 Revenue Growth Lowered Sep 9, 2019 Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor Jul 1, 2019 FDA Approves Foundation Medicine CDx Test for Lynparza May 30, 2019 Caris Life Sciences Inks CDx Collaboration With Debiopharm Apr 4, 2019 Myriad Genetics, AstraZeneca, Merck Expand BRCA CDx Collaboration Dec 7, 2018 Novartis Drug Shows Promise in PIK3CA Mutated Breast Cancer, Potential Utility of ctDNA Testing Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.